Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Distribution

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Revenue projections:

Revenue projections for HSIC
Revenue projections for HSIC

Revenues for HSIC are forecasted to decline from last year's levels, prompting caution among investors. When revenues fall, it can have a significant negative impact on the company's bottom line, reducing profitability and making the stock less attractive to risk-averse investors.

Financial Ratios:

currentRatio 1.383000
forwardPE 12.676384
debtToEquity 71.736000
earningsGrowth 0.136000
revenueGrowth 0.077000
grossMargins 0.311360
operatingMargins 0.052950
trailingEps 3.270000
forwardEps 5.884170

HSIC's current ratio of 1.383 shows that the company has ample resources to service its short-term debt. This indicates a solid financial position, as HSIC can rely on its cash reserves and current assets to cover its immediate liabilities without strain.
Henry Schein, Inc.'s Forward PE being in a good range indicates the stock is priced well relative to its earnings. It is not overvalued, leaving space for future growth, making it an appealing option for investors interested in long-term value appreciation.
HSIC's forward EPS surpassing its trailing EPS signals that the company is anticipated to be more profitable this year than last. This growth expectation highlights HSIC's potential for increased earnings and a stronger financial performance in the upcoming year.

Price projections:

Price projections for HSIC
Price projections for HSIC

Over time, price projections for HSIC have risen steadily, pointing to growing optimism among analysts about the company's future. This upward trend suggests a positive outlook for HSIC's continued growth.

Insider Transactions:

Insider Transactions for HSIC
Insider Transactions for HSIC


HSIC experienced 8 sell transactions with market price of 76.97249984741211 per share.1 HSIC stock purchases took place, with market price of 65.9000015258789.The increased selling activity around HSIC's current price levels may indicate further downside risk. If this trend continues, the stock's price could face additional declines as selling pressure intensifies.

Recommendation changes over time:

Recommendations trend for HSIC
Recommendations trend for HSIC


Analysts have maintained a buy bias for HSIC, which could prompt investors to consider the stock as a viable investment. With this positive outlook, HSIC is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.